Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The following study is being conducted to explore the safety and effectiveness of a new chemical entity called NXN-188 in subjects with a history of migraine with aura. In this study subjects will treat two attacks of migraine with aura during the aura phase - once with placebo and once with NXN-188.
Epistemonikos ID: cc3148b2ab373d6893474602aaeb6d753f93ad2e
First added on: May 05, 2024